Director

• Define and implement Pharmacometrics strategies
• Lead the development and execution of Pharmacometrics (PMx) plans for New Chemical Entities (NCEs) and New Biological Entities (NBEs) to support regulatory submissions.
• Drive the PMx strategy across non-clinical and clinical projects, contributing to modeling and simulation activities to guide drug development decisions.
• Identify opportunities to leverage Model-Informed Drug Development (MIDD) to optimize study designs and enhance program success.
• Inform drug development strategies to support decision-making and successful approvals.
• Ensure the timely delivery and high quality of PMx documents, including dataset specifications, analysis plans, and reports.
• Collaboratively author and review key documents where PMx is a contributor, such as clinical development plans, pediatric investigational plans, and submission packages.
• Represent the PMx group in project teams and cross-functional initiatives.
• Collaborate with teams across early development, pharmacology, biometry, and clinical operations.
• Conduct or oversee hands-on PMx activities and perform modeling and simulation activities, including population PK/PD, exposure–response, disease progression, and minimal PBPK modeling.
• Plan, budget, and manage subcontracted PMx activities, including PK/PD and PBPK studies.

Pharmacometrician Director

Associate Director, Affordability Analytics, Reporting

Intake Director

Director, Access Strategy – Dupixent, Rhinology, Allergy, Gastroenterology

Senior Director, Transplant Access Strategy, Provider Accounts